Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance.
Nat Cell Biol. 2021 Nov;23(11):1187-1198. doi: 10.1038/s41556-021-00781-z. Epub 2021 Nov 4.
Nat Cell Biol. 2021.
PMID: 34737445
Real-World Efficacy of COVID-19 Pre-Exposure Prophylaxis with Tixagevimab/Cilgavimab in People with Multiple Sclerosis.
Elias LB, Jaber A, Manzano M, Leekoff M, Sylvester A, Tremblay MA.
Elias LB, et al. Among authors: jaber a.
Vaccines (Basel). 2023 Dec 15;11(12):1855. doi: 10.3390/vaccines11121855.
Vaccines (Basel). 2023.
PMID: 38140258
Free PMC article.
Item in Clipboard
COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy.
Jaber A, Patel M, Sylvester A, Yarussi M, Kalina JT, Mendoza JP, Avila RL, Tremblay MA.
Jaber A, et al.
Neurol Ther. 2023 Apr;12(2):687-700. doi: 10.1007/s40120-023-00448-x. Epub 2023 Feb 16.
Neurol Ther. 2023.
PMID: 36792812
Free PMC article.
Item in Clipboard
Cite
Cite